Related Experiment Video
Updated: Aug 24, 2026

Chronic Intermittent Ethanol Vapor Exposure Paired with Two-Bottle Choice to Model Alcohol Use Disorder
Published on: June 23, 2023
Extended blood ethyl glucuronide persistence after controlled ethanol administration: Implications for
Young-Hoon Jo1, Min-Hui Son1, Hyejin Choi2
1Forensic Chemistry Division, National Forensic Service, Wonju, Republic of Korea.
None:
Delayed blood sampling complicates forensic interpretation in driving-under-the-influence investigations when ethanol concentrations have declined below routine reporting thresholds. Blood ethyl glucuronide (EtG) may provide evidence of recent alcohol exposure, but its late-phase persistence under controlled conditions remains incompletely characterized. This secondary analysis evaluated blood EtG persistence following controlled administration of 1.0 g/kg ethanol in 34 participants using a predefined operational threshold of 0.09 mg/L and sampling through 15 h after completion of drinking. The operational persistence event was defined as the first scheduled sample with EtG < 0.09 mg/L, whereas participants remaining at or above the threshold at 15 h were right-censored. Kaplan-Meier analysis estimated a median operational persistence time of 15 h (95% CI, 14h-not reached). At the final 15-h sampling time, 13 of 34 participants (38%) remained at or above 0.09 mg/L; therefore, the upper boundary of persistence was not observed. Last observed EtG-positive sampling times ranged from 10 to 15 h, and terminal EtG half-lives ranged from 1.4 to 2.9 h. Five forensic cases with blood ethanol concentrations below the laboratory reporting threshold and delayed blood sampling were reviewed descriptively. Incomplete and unverified drinking and clinical histories precluded quantitative comparison with the controlled concentration-time data. These findings provide late-phase blood EtG observations relevant to delayed DUI investigations but do not provide a validated basis for estimating ethanol dose or exact drinking time from a single EtG concentration.
Related Concept Videos
Hepatic Drug Excretion: Enterohepatic Cycling
Post-release drugs and metabolites can be reabsorbed into the body from the intestine. For conjugated metabolites like glucuronides, reabsorption requires enzymatic hydrolysis by intestinal microflora. This...
First Pass Effect
Depending on the route of administration, drugs can be metabolized in the liver, intestine, lungs, and vasculature. Orally administered drugs are first absorbed through the...

